Read Time:36 Second
U.S.-listed shares of Bayer AG BAYRYHU:BAYER rallied about 5% in trading on Wednesday after the German pharmaceutical company said it named Bill Anderson as its new CEO, effective June 1. Anderson, 56, most recently served as CEO of Roche Holding AG’s CH:ROG pharmaceuticals business. He is also the former CEO of Genentech, which is also part of Roche. Bayer’s longtime CEO Werner Baumann will retire in May. Bayer’s stock has gained 30.5% since the start of the year, while the S&P 500 SPX is up 8.6%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
